|
WDR75 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.599400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.174080E-02 |
| Normal-vs-Stage2 |
3.20030000000582E-06 |
| Normal-vs-Stage3 |
2.807200E-04 |
| Normal-vs-Stage4 |
1.141210E-01 |
| Stage1-vs-Stage2 |
5.377100E-04 |
| Stage1-vs-Stage3 |
6.172100E-02 |
| Stage1-vs-Stage4 |
8.890800E-01 |
| Stage2-vs-Stage3 |
6.066400E-02 |
| Stage2-vs-Stage4 |
5.299600E-03 |
| Stage3-vs-Stage4 |
1.625030E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.980640E-03 |
| Normal-vs-AfricanAmerican |
8.876900E-03 |
| Normal-vs-Asian |
4.290000E-01 |
| Caucasian-vs-AfricanAmerican |
5.074400E-01 |
| Caucasian-vs-Asian |
7.836100E-02 |
| AfricanAmerican-vs-Asian |
8.283900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.204120E-02 |
| Normal-vs-Female |
2.806500E-04 |
| Male-vs-Female |
5.090200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.540300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.22819999999846E-05 |
| Normal-vs-Age(61-80Yrs) |
2.702400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.378000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.821700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.862200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.419100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.283000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.901200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.952200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.904000E-01 |
| Classical-VS-Follicular |
7.95059995617464E-09 |
| Classical-VS-Other |
9.526800E-01 |
| Classical-VS-Normal |
1.461190E-01 |
| Tall-VS-Follicular |
1.864360E-02 |
| Tall-VS-Other |
7.671000E-01 |
| Tall-VS-Normal |
1.880960E-01 |
| Follicular-VS-Other |
8.942200E-02 |
| Follicular-VS-Normal |
7.65590000284533E-08 |
| Other-VS-Normal |
5.676800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.75809999967281E-07 |
| Normal-vs-N1 |
3.542000E-01 |
| N0-vs-N1 |
7.001400E-03 |
|
|
